Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Recruiting

I'm Interested

Trial ID: NCT05940324

Purpose

The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.

Official Title

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Stanford Investigator(s)

Carolyn Rodriguez
Carolyn Rodriguez

Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

Eligibility


Eligibility Criteria for Participants with OCD:

Inclusion Criteria:

   - Ages 18-65

   - Meet the criteria for OCD diagnosis

   - Failed at least 1 prior trial of standard first-line OCD treatment

   - Agree to the following lifestyle modifications: comply with requirements for fasting
   prior to the Experimental Session, not enroll in any other interventional clinical
   trials during the duration of the study, and commit to medication study procedures.

   - Able to provide informed consent

Exclusion Criteria:

   - prior naltrexone or ketamine use/exposure

   - Any current or past medical/psychiatric condition that makes participation unsafe in
   the opinion of the investigator or study physician

   - Pregnant or nursing, or able to become pregnant and are not practicing an effective
   means of birth control

   - the presence of metal in the body that is contraindicated for MRI scans

Eligibility Criteria for Healthy Volunteers:

Inclusion Criteria:

   - Ages 18-65

   - Able to provide informed consent

Exclusion Criteria:

   - current or past use of psychotropic medication

   - pregnant or nursing females

   - the presence of metal in the body that is contraindicated for MRI scans

Intervention(s):

drug: Ketamine

drug: Naltrexone Pill

other: Placebo pill

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Pavithra Mukunda, MS
6504972578